These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 16440328

  • 21. Role of anti-idiotype vaccines in the modern treatment of human follicular lymphoma.
    Bendandi M.
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):65-72. PubMed ID: 12113135
    [Abstract] [Full Text] [Related]

  • 22. Plasmid DNA- and messenger RNA-based anti-cancer vaccination.
    Weide B, Garbe C, Rammensee HG, Pascolo S.
    Immunol Lett; 2008 Jan 15; 115(1):33-42. PubMed ID: 18006079
    [Abstract] [Full Text] [Related]

  • 23. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A, Ojeda A, López-Fuertes L, Timón M, Altet L, Solano-Gallego L, Sánchez-Robert E, Francino O, Alberola J.
    Vaccine; 2007 Nov 14; 25(46):7962-71. PubMed ID: 17942199
    [Abstract] [Full Text] [Related]

  • 24. New approaches in vaccine development.
    Leclerc C.
    Comp Immunol Microbiol Infect Dis; 2003 Oct 14; 26(5-6):329-41. PubMed ID: 12818620
    [Abstract] [Full Text] [Related]

  • 25. In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer.
    Garcia-Hernandez Mde L, Gray A, Hubby B, Kast WM.
    Cancer Res; 2007 Feb 01; 67(3):1344-51. PubMed ID: 17283172
    [Abstract] [Full Text] [Related]

  • 26. Chemical adjuvants for plasmid DNA vaccines.
    Greenland JR, Letvin NL.
    Vaccine; 2007 May 10; 25(19):3731-41. PubMed ID: 17350735
    [Abstract] [Full Text] [Related]

  • 27. Hsp-based tumor vaccines: state-of-the-art and future directions.
    Takakura Y, Takemoto S, Nishikawa M.
    Curr Opin Mol Ther; 2007 Aug 10; 9(4):385-91. PubMed ID: 17694451
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.
    Eur J Immunol; 2009 Oct 10; 39(10):2725-36. PubMed ID: 19637230
    [Abstract] [Full Text] [Related]

  • 30. DNA vaccines: precision tools for activating effective immunity against cancer.
    Rice J, Ottensmeier CH, Stevenson FK.
    Nat Rev Cancer; 2008 Feb 10; 8(2):108-20. PubMed ID: 18219306
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H, Shurin MR, Han B.
    Expert Rev Vaccines; 2007 Jun 10; 6(3):333-45. PubMed ID: 17542749
    [Abstract] [Full Text] [Related]

  • 33. Immunoprevention of cancer: time to reconsider timing of vaccination against cancer.
    Spisek R.
    Expert Rev Anticancer Ther; 2006 Dec 10; 6(12):1689-91. PubMed ID: 17181481
    [No Abstract] [Full Text] [Related]

  • 34. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction.
    Mills KH.
    Immunol Lett; 2009 Feb 21; 122(2):108-11. PubMed ID: 19100777
    [Abstract] [Full Text] [Related]

  • 35. Cancer vaccines: a promising cancer therapy against all odds.
    Silk AW, Finn OJ.
    Future Oncol; 2007 Jun 21; 3(3):299-306. PubMed ID: 17547525
    [Abstract] [Full Text] [Related]

  • 36. Cytokine adjuvants for vaccine therapy of neoplastic and infectious disease.
    Decker WK, Safdar A.
    Cytokine Growth Factor Rev; 2011 Aug 21; 22(4):177-87. PubMed ID: 21862380
    [Abstract] [Full Text] [Related]

  • 37. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A, Spyridopoulou K, Pappa A, Chlichlia K.
    Pharmacol Ther; 2016 Sep 21; 165():32-49. PubMed ID: 27235391
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.